475
Views
16
CrossRef citations to date
0
Altmetric
Articles

Time-course effect of ultrasmall superparamagnetic iron oxide nanoparticles on intracellular iron metabolism and ferroptosis activation

ORCID Icon, , , , , , , , ORCID Icon & ORCID Icon show all
Pages 366-379 | Received 31 Jan 2020, Accepted 29 Dec 2020, Published online: 16 Jan 2021

References

  • Ali, A., H. Zafar, M. Zia, I. Ul Haq, A. R. Phull, J. S. Ali, and A. Hussain. 2016. “Synthesis, Characterization, Applications, and Challenges of Iron Oxide Nanoparticles.” Nanotechnology, Science and Applications 9: 49–67. doi:10.2147/NSA.S99986.
  • Ayala, A., M. F. Munoz, and S. Arguelles. 2014. “Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal.” Oxidative Medicine and Cellular Longevity 2014: 360438. doi:10.1155/2014/360438.
  • Buyukhatipoglu, K., T. A. Miller, and A. M. Clyne. 2009. “Flame Synthesis and in Vitro Biocompatibility Assessment of Superparamagnetic Iron Oxide Nanoparticles: Cellular Uptake, Toxicity and Proliferation studies.” Journal of Nanoscience and Nanotechnology 9 (12): 6834–6843. doi:10.1166/jnn.2009.1477.
  • Chitambar, C. R., and J. P. Wereley. 1998. “Transferrin Receptor-Dependent and -Independent Iron Transport in Gallium-Resistant Human Lymphoid Leukemic Cells.” Blood 91 (12): 4686–4693. doi:10.1182/blood.V91.12.4686.
  • Conrad, M., J. P. Angeli, P. Vandenabeele, and B. R. Stockwell. 2016. “Regulated Necrosis: Disease Relevance and Therapeutic Opportunities.” Nature Reviews. Drug Discovery 15 (5): 348–366. doi:10.1038/nrd.2015.6.
  • Del Puerto-Nevado, L., A. Santiago-Hernandez, S. Solanes-Casado, N. Gonzalez, M. Ricote, M. Corton, I. Prieto, et al. 2019. “Diabetes-Mediated Promotion of Colon Mucosa Carcinogenesis is Associated with Mitochondrial Dysfunction.” Molecular Oncology 13 (9): 1887–1897. doi:10.1002/1878-0261.12531.
  • Dixon, S. J., and B. R. Stockwell. 2019. “The Hallmarks of Ferroptosis.” Annual Review of Cancer Biology 3 (1): 35–54. doi:10.1146/annurev-cancerbio-030518-055844.
  • Dixon, S. J., K. M. Lemberg, M. R. Lamprecht, R. Skouta, E. M. Zaitsev, C. E. Gleason, D. N. Patel, et al. 2012. “Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death.” Cell 149 (5): 1060–1072. doi:10.1016/j.cell.2012.03.042.
  • Doll, S., B. Proneth, Y. Y. Tyurina, E. Panzilius, S. Kobayashi, I. Ingold, M. Irmler, et al. 2017. “ACSL4 Dictates Ferroptosis Sensitivity by Shaping Cellular Lipid Composition.” Nature Chemical Biology 13 (1): 91–98. doi:10.1038/nchembio.2239.
  • Friedmann Angeli, J. P., D. V. Krysko, and M. Conrad. 2019. “Ferroptosis at the Crossroads of Cancer-Acquired Drug Resistance and Immune Evasion.” Nature Reviews. Cancer 19 (7): 405–414. doi:10.1038/s41568-019-0149-1.
  • Fulda, S., A. M. Gorman, O. Hori, and A. Samali. 2010. “Cellular Stress Responses: Cell Survival and Cell Death.” International Journal of Cell Biology 2010: 214074. doi:10.1155/2010/214074.
  • Gao, G., H. Wu, W. Gao, Y. Zhang, P. Huang, and D. Cui. 2011. “Preparation of FeCO3–Fe3O4 Nanoparticles and Flower-like Assemblies via a One-Step Hydrothermal Method.” CrystEngComm 13 (23): 6950–6954. doi:10.1039/c1ce05994g.
  • Gao, M., P. Monian, N. Quadri, R. Ramasamy, and X. Jiang. 2015. “Glutaminolysis and Transferrin Regulate Ferroptosis.” Molecular Cell 59 (2): 298–308. doi:10.1016/j.molcel.2015.06.011.
  • Gao, M., P. Monian, Q. Pan, W. Zhang, J. Xiang, and X. Jiang. 2016. “Ferroptosis is an Autophagic Cell Death Process.” Cell Research 26 (9): 1021–1032. doi:10.1038/cr.2016.95.
  • Harrison, P. M., and P. Arosio. 1996. “The Ferritins: Molecular Properties, Iron Storage Function and Cellular Regulation.” Biochimica Et Biophysica Acta (Bba) - Bioenergetics 1275 (3): 161–203. doi:10.1016/0005-2728(96)00022-9.
  • Hassannia, B., P. Vandenabeele, and T. Vanden Berghe. 2019. “Targeting Ferroptosis to Iron out Cancer.” Cancer Cell 35 (6): 830–849. doi:10.1016/j.ccell.2019.04.002.
  • Hershko, C. 2007. “Iron Loading and Its Clinical Implications.” American Journal of Hematology 82 (12): 1147–1148. doi:10.1002/ajh.21070.
  • Hou, W., Y. Xie, X. Song, X. Sun, M. T. Lotze, H. J. Zeh, 3rd, R. Kang, et al. 2016. “Autophagy Promotes Ferroptosis by Degradation of Ferritin.” Autophagy 12 (8): 1425–1428. doi:10.1080/15548627.2016.1187366.
  • Ingold, I., C. Berndt, S. Schmitt, S. Doll, G. Poschmann, K. Buday, A. Roveri, et al. 2018. “Selenium Utilization by GPX4 is Required to Prevent Hydroperoxide-Induced Ferroptosis.” Cell 172 (3): 409–422. doi:10.1016/j.cell.2017.11.048.
  • Jomova, K., and M. Valko. 2011. “Importance of Iron Chelation in Free Radical-Induced Oxidative Stress and Human Disease.” Current Pharmaceutical Design 17 (31): 3460–3473. doi:10.2174/138161211798072463.
  • Kagan, V. E., G. Mao, F. Qu, J. P. F. Angeli, S. Doll, C. S. Croix, H. H. Dar, et al. 2017. “Oxidized Arachidonic and Adrenic PEs Navigate Cells to Ferroptosis.” Nature Chemical Biology 13 (1): 81–90. doi:10.1038/nchembio.2238.
  • Kim, S. E., L. Zhang, K. Ma, M. Riegman, F. Chen, I. Ingold, M. Conrad, et al. 2016. “Ultrasmall Nanoparticles Induce Ferroptosis in Nutrient-Deprived Cancer Cells and Suppress Tumour Growth.” Nature Nanotechnology 11 (11): 977–985. doi:10.1038/nnano.2016.164.
  • Lin, M., H. Huang, Z. Liu, Y. Liu, J. Ge, and Y. Fang. 2013. “Growth-Dissolution-Regrowth Transitions of Fe3O4 Nanoparticles as Building Blocks for 3D Magnetic Nanoparticle Clusters under Hydrothermal Conditions.” Langmuir: The ACS Journal of Surfaces and Colloids 29 (49): 15433–15441. doi:10.1021/la403577y.
  • Liu, J., P. Wang, X. Zhang, L. Wang, D. Wang, Z. Gu, J. Tang, et al. 2016. “Rapid Degradation and High Renal Clearance of Cu3BiS3 Nanodots for Efficient Cancer Diagnosis and Photothermal Therapy in Vivo.” ACS Nano 10 (4): 4587–4598. doi:10.1021/acsnano.6b00745.
  • Liu, M., B. Liu, Q. Liu, K. Du, Z. Wang, and N. He. 2019. “Nanomaterial-Induced Ferroptosis for Cancer Specific Therapy.” Coordination Chemistry Reviews 382: 160–180. doi:10.1016/j.ccr.2018.12.015.
  • Lu, B., X. B. Chen, M. D. Ying, Q. J. He, J. Cao, and B. Yang. 2018. “The Role of Ferroptosis in Cancer Development and Treatment Response.” Frontiers in Pharmacology 8: 992. doi:10.3389/fphar.2017.00992.
  • Ma, P., H. Xiao, C. Yu, J. Liu, Z. Cheng, H. Song, X. Zhang, et al. 2017. “Enhanced Cisplatin Chemotherapy by Iron Oxide Nanocarrier-Mediated Generation of Highly Toxic Reactive Oxygen Species.” Nano Letters 17 (2): 928–937. doi:10.1021/acs.nanolett.6b04269.
  • McCarthy, R. C., J. C. Sosa, A. M. Gardeck, A. S. Baez, C. H. Lee, and M. Wessling-Resnick. 2018. “Inflammation-Induced Iron Transport and Metabolism by Brain Microglia.” The Journal of Biological Chemistry 293 (20): 7853–7863. doi:10.1074/jbc.RA118.001949.
  • Nordmeyer, D., P. Stumpf, D. Groger, A. Hofmann, S. Enders, S. B. Riese, J. Dernedde, et al. 2014. “Iron Oxide Nanoparticles Stabilized with Dendritic Polyglycerols as Selective MRI Contrast Agents.” Nanoscale 6 (16): 9646–9654. doi:10.1039/c3nr04793h.
  • Ou, W., R. S. Mulik, A. Anwar, J. G. McDonald, X. He, and I. R. Corbin. 2017. “Low-Density Lipoprotein Docosahexaenoic Acid Nanoparticles Induce Ferroptotic Cell Death in Hepatocellular Carcinoma.” Free Radical Biology & Medicine 112: 597–607. doi:10.1016/j.freeradbiomed.2017.09.002.
  • Peng, X. H., X. Qian, H. Mao, A. Y. Wang, Z. G. Chen, S. Nie, and D. M. Shin. 2008. “Targeted Magnetic Iron Oxide Nanoparticles for Tumor Imaging and Therapy.” International Journal of Nanomedicine 3 (3): 311–321. doi:10.2147/ijn.s2824.
  • Pogribny, I. P. 2010. “Ferroportin and Hepcidin: A New Hope in Diagnosis, Prognosis, and Therapy for Breast Cancer.” Breast Cancer Research 12 (5): 314. doi:10.1186/bcr2641.
  • Sammarco, M. C., S. Ditch, A. Banerjee, and E. Grabczyk. 2008. “Ferritin L and H Subunits Are Differentially Regulated on a post-transcriptional level.” Journal of Biological Chemistry 283 (8): 4578–4587. doi:10.1074/jbc.M703456200.
  • Shen, Z., J. Song, B. C. Yung, Z. Zhou, A. Wu, and X. Chen. 2018. “Emerging Strategies of Cancer Therapy Based on Ferroptosis.” Advanced Materials 30 (12): e1704007. doi:10.1002/adma.201704007.
  • Stockwell, B. R., J. P. Friedmann Angeli, H. Bayir, A. I. Bush, M. Conrad, S. J. Dixon, S. Fulda, et al. 2017. “Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease.” Cell 171 (2): 273–285. doi:10.1016/j.cell.2017.09.021.
  • Tonnus, W., and A. Linkermann. 2017. “The in Vivo Evidence for Regulated Necrosis.” Immunological Reviews 277 (1): 128–149. doi:10.1111/imr.12551.
  • Wang, L., T. Zhang, P. Li, W. Huang, J. Tang, P. Wang, J. Liu, et al. 2015. “Use of Synchrotron Radiation-Analytical Techniques to Reveal Chemical Origin of Silver-Nanoparticle Cytotoxicity.” ACS Nano 9 (6): 6532–6547. doi:10.1021/acsnano.5b02483.
  • Wang, S., F. Li, R. Qiao, X. Hu, H. Liao, L. Chen, J. Wu, et al. 2018. “Arginine-Rich Manganese Silicate Nanobubbles as a Ferroptosis-Inducing Agent for Tumor-Targeted Theranostics.” ACS Nano 12 (12): 12380–12392. doi:10.1021/acsnano.8b06399.
  • Wenzel, S. E., Y. Y. Tyurina, J. Zhao, C. M. St Croix, H. H. Dar, G. Mao, V. A. Tyurin, et al. 2017. “PEBP1 Wardens Ferroptosis by Enabling Lipoxygenase Generation of Lipid Death Signals.” Cell 171 (3): 628–641. doi:10.1016/j.cell.2017.09.044.
  • Yagoda, N., M. von Rechenberg, E. Zaganjor, A. J. Bauer, W. S. Yang, D. J. Fridman, A. J. Wolpaw, et al. 2007. “RAS-RAF-MEK-Dependent Oxidative Cell Death Involving Voltage-Dependent Anion Channels.” Nature 447 (7146): 864–868. doi:10.1038/nature05859.
  • Yamanishi, H., S. Iyama, Y. Yamaguchi, Y. Kanakura, and Y. Iwatani. 2003. “Total Iron-Binding Capacity Calculated from Serum Transferrin Concentration or Serum Iron Concentration and Unsaturated Iron-Binding Capacity.” Clinical Chemistry 49 (1): 175–178. doi:10.1373/49.1.175.
  • Yang, W. S., and B. R. Stockwell. 2016. “Ferroptosis: Death by Lipid Peroxidation.” Trends in Cell Biology 26 (3): 165–176. doi:10.1016/j.tcb.2015.10.014.
  • Yang, W. S., R. Sri Ramaratnam, M. E. Welsch, K. Shimada, R. Skouta, V. S. Viswanathan, J. H. Cheah, et al. 2014. “Regulation of Ferroptotic Cancer Cell Death by GPX4.” Cell 156 (1–2): 317–331. doi:10.1016/j.cell.2013.12.010.
  • Yuan, H., X. Li, X. Zhang, R. Kang, and D. Tang. 2016. “Identification of ACSL4 as a Biomarker and Contributor of Ferroptosis.” Biochemical and Biophysical Research Communications 478 (3): 1338–1343. doi:10.1016/j.bbrc.2016.08.124.
  • Zhou, H., J. Tang, J. Li, W. Li, Y. Liu, and C. Chen. 2017. “In Vivo Aggregation-Induced Transition between T1 and T2 Relaxations of Magnetic Ultra-Small Iron Oxide Nanoparticles in Tumor Microenvironment.” Nanoscale 9 (9): 3040–3050. doi:10.1039/c7nr00089h.
  • Zhou, Y., Y. Shen, C. Chen, X. Sui, J. Yang, L. Wang, and J. Zhou. 2019. “The Crosstalk between Autophagy and Ferroptosis: What Can we Learn to Target Drug Resistance in Cancer?” Cancer Biology & Medicine 16 (4): 630–646. doi:10.20892/j.issn.2095-3941.2019.0158.
  • Zhou, Z., J. Song, R. Tian, Z. Yang, G. Yu, L. Lin, G. Zhang, et al. 2017. “Activatable Singlet Oxygen Generation from Lipid Hydroperoxide Nanoparticles for Cancer Therapy.” Angewandte Chemie 56 (23): 6492–6496. doi:10.1002/anie.201701181.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.